Search
01/09/2025
A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries
Voss, EA, Yuan, Z, Ali, SR, Bosan, R, Eworuke, E, Brewster, J, Vlacho, B, Fernández-Camins, B, Fernández-Bertolín, S, Fonseca, S, Jeffcoat, C, Wang, L. A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries. DIABETES OBESITY & METABOLISM. 2025; 27(9)DOI:10.1111/dom.16574. PMID:40605139. IF:5.700(Q1/2D).
01/09/2025
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(9)DOI:10.1210/clinem/dgaf288. PMID:40652453. IF:5.100(Q1/2D).
01/09/2025
Integration of Artificial Intelligence-Enhanced Capsule Endoscopy in Clinical Practice: A Review of Market-Available Tools for Clinical Practice
Giordano, A, Romero-Mascarell, C, González-Suárez, B, Guarner-Argente, C. Integration of Artificial Intelligence-Enhanced Capsule Endoscopy in Clinical Practice: A Review of Market-Available Tools for Clinical Practice. DIGESTIVE DISEASES AND SCIENCES. 2025; 70(9)DOI:10.1007/s10620-025-09099-4. PMID:40490597. IF:2.500(Q2/5D).
01/09/2025
ANCA associated pulmonary fibrosis: vasculitis or not vasculitis
Codes-Méndez, H, Castillo, D, Moya-Alvarado, P, Giménez-Palleiro, A, Castellvi, I. ANCA associated pulmonary fibrosis: vasculitis or not vasculitis. CURRENT OPINION IN PULMONARY MEDICINE. 2025; 31(5)DOI:10.1097/MCP.0000000000001187. PMID:40548517. IF:2.800(Q2/5D).
01/09/2025
Trends in time to withdrawal and full approval of accelerated approval cancer drug indications (1992-2024)
Jenei, K, Hahn, G, Kesselheim, AS, Tibau, A. Trends in time to withdrawal and full approval of accelerated approval cancer drug indications (1992-2024). Journal Of Cancer Policy. 2025; 45DOI:10.1016/j.jcpo.2025.100597. PMID:40472969. IF:(Q/D).
01/09/2025
Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial
Remon, J, Bironzo, P, Girard, N, Bigay-Game, L, Juan-Vidal, O, de Castro, J, Reguart, N, Greillier, L, Cousin, S, Dansin, E, Majem, M, Bernabe, R, Martinez, JM, Diaz, M, Meya, A, Alcalá-López, D, Garcia-Sanz, A, Righi, L, Novello, S, Besse, B. Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial. LANCET ONCOLOGY. 2025; 26(9)DOI:10.1016/S1470-2045(25)00300-6. PMID:40907517. IF:35.900(Q1/1D).
01/09/2025
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial
Tombal, B, Choudhury, A, Saad, F, Gallardo, E, Soares, A, Loriot, Y, Mcdermott, R, Rodriguez-Vida, A, Velho, PI, Nolè, F, Cruz, F, Roumeguere, T, Daugaard, G, Yamamura, R, Bompas, E, Maroto, P, Veiga, FG, Skoneczna, I, Trindade, KMD, Carcano, FM, Lecouvet, F, Coens, C, Poncet, C, Fournier, B, Gillessen, S, Crua, F. Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial. ANNALS OF ONCOLOGY. 2025; 36(9)DOI:10.1016/j.annonc.2025.05.011. PMID:40450503. IF:65.400(Q1/1D).
01/09/2025
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis
Mcloughlin, MA, Kovilakam, SC, Dunn, WG, Gu, MX, Tobin, J, Pershad, Y, Williams, N, Leongamornlert, D, Dawson, K, Bond, L, Marando, L, Wen, S, Wilson, R, Valenzano, G, Symeonidou, V, Rak, J, Damaskou, A, Gozdecka, M, Liu, XX, Barcena, C, Nomdedeu, J, Costeas, P, Dimitriou, ID, Fiorillo, E, Orrù, V, de Almeida, JG, Mckerrell, T, Cullen, M, Mohorianu, I, Foukaneli, T, Warren, AJ, Wong, C, Follows, G, Godfrey, AL, Gudgin, E, Cucca, F, Mckinney, E, Baxter, EJ, Gerstung, M, Mitchell, J, Wiseman, D, Bick, AG, Fabre, M, Quiros, PM, Nangalia, J, Kar, S, Vassiliou, GS. Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis. NATURE GENETICS. 2025; 57(9)DOI:10.1038/s41588-025-02296-x. PMID:40877435. IF:29.000(Q1/1D).
01/09/2025
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT
Perruccio, K, Ward, KN, Tridello, G, Knelange, N, Zeiser, R, Franke, GN, Sirvent, A, Einsele, H, Vicent, MG, Navarro, JMF, Contentin, N, Collin, M, Martino, R, Gambella, M, Sengeloev, H, Passweg, J, Snowden, J, Nagler, A, Kulagin, A, Gabriel, M, Kröger, N, Cascon, MJP, Yeshurun, M, Güngör, T, Robin, C, Clark, A, Duarte, ML, Amor, AA, Itala-Remes, M, Mikulska, M, Styczynski, J, de la Camara, R, Ljungman, P, Averbuch, D, Cesaro, S. Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT. BONE MARROW TRANSPLANTATION. 2025; 60(9)DOI:10.1038/s41409-025-02638-7. PMID:40461849. IF:5.200(Q1/1D).
01/09/2025
Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
Giménez, E, Cadenas, IG, Piñana, JL, Albert, E, Vázquez, L, Avendaño, A, Cabrero, M, Esquirol, A, Martino, R, López-Jiménez, J, Cuesta, MA, Humala, K, Villar, S, Rovira, M, Heras, I, Zudaire, T, Arroyo, I, Zabalza, A, Aguado, B, Solano, C, Navarro, D. Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study. Transplant Infectious Disease. 2025; 27(5)DOI:10.1111/tid.70080. PMID:40674366. IF:2.600(Q1/1D).
01/09/2025
Blood-based biomarkers for Alzheimer's disease: Positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology
Suárez-Calvet, M, Abdelnour, C, Alcolea, D, Mendióroz-Iriarte, M, Balasa, M, Morenas-Rodríguez, E, Puig-Pijoan, A, Sánchez-Juan, P, Villarejo-Galende, A, Sánchez-Valle, R. Blood-based biomarkers for Alzheimer's disease: Positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology. NEUROLOGIA. 2025; 40(7)DOI:10.1016/j.nrleng.2025.07.004. PMID:40685136. IF:3.100(Q2/4D).
01/09/2025
Determinantes de tuberculosis en la población que ingresa en prisiones de Cataluña
Marco, A., Solé, N., Prieto-García, R, Abdo, I.J., Millet J.P., Turu, E.. Determinantes de tuberculosis en la población que ingresa en prisiones de Cataluña. Revista Española de Sanidad Penitenciaria. 2025; 27(3)DOI:. PMID:. IF:(Q/D).
01/09/2025
Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper
García-Cosío Carmena, MD, Farrero, M, Blasco Peiró, MT, Crespo, M, Delgado Jiménez, J, Díaz Molina, B, Fernández Rivera, C, Garrido Bravo, IP, López Jiménez, V, Melilli, E, Mirabet Pérez, S, Pérez Tamajón, ML, Rangel Sousa, D, Rodrigo, E, Cruzado, JM, Hernández Marrero, D. Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper. TRANSPLANTATION. 2025; 109(9)DOI:10.1097/TP.0000000000005302. PMID:39928546. IF:5.000(Q1/1D).
01/09/2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Audisio, A, Gallio, C, Velenik, V, Meillat, H, Ruiz-Garcia, E, Riesco, MC, Alecha, JS, Rasschaert, G, Carvalho, C, Randrian, V, Kirac, I, Hernando, J, Artac, M, O'Connor, JM, Waldhorn, I, Braam, PM, Shamseddine, A, Moretto, R, de la Pinta, C, De Felice, F, Dulskas, A, Lopez-Bravo, DP, Vanden Bulcke, A, Bock, F, Deleporte, A, van den Eynde, M, Geboes, KP, Loi, M, Messina, M, Houlze-Laroye, C, Puccini, A, Pastorino, A, Papamichael, D, Fiore, M, Sur, D, Eid, M, Antoun, C, Salati, M, Garajova, I, Jakubauskas, M, Tomasek, J, Pinto, CMS, Schwingel, J, Morano, F, Adams, RA, Dermine, A, Chau, A, Javed, MA, Ghidini, M, Fiorica, F, Montenegro, P, Petrillo, A, Spolverato, G, Margalef, NM, Diaz, M, Baratelli, C, Puleo, F, Karampeazis, A, Sert, F, Gilliaux, Q, De Stefano, A, Liberale, G, Moretti, L, Martinive, P, Thomas, VD, Staggs, V, Saad, ED, Van Laethem, JL, Sclafani, F. Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncology. 2025; 11(9)DOI:10.1001/jamaoncol.2025.2026. PMID:40638097. IF:20.100(Q1/1D).
01/09/2025
Recommended Phase 2 Dose (RP2D) Determination of Bleximenib in Combination With Venetoclax plus Azacitidine (VEN plus AZA): Phase Ib Study in Newly Diagnosed (ND) and Relapsed/ Refractory (R/R) Acute Myeloid Leukemia (AML) With KMT2A or NPM1 Alterations
Wei, AH, Reyner, JE, Garciaz, S, Aldoss, I, Piérola, A, Allred, A, Dominguez, JMA, Barreyro, L, Bories, P, Daskalakis, N, Porta, MGD, Döhner, H, D'Souza, A, Dugan, J, Fathi, A, Fedele, P, Ferrante, L, Kobos, R, Gaj, S, Diaz, AG, Paniagua, SG, Guttke, C, Gyan, E, Hiebert, B, Jabbour, E, Trancucci, D, Bamidele, T, Jentzsch, M, Kantarjian, H, Konopleva, M, Krönke, J, Hütter-Krönke, ML, Loefgren, C, Lomas, O, Mancini, V, Mantzaris, I, Morillo, D, O'Nions, J, Packman, K, Papayannidis, C, Récher, C, Roellig, C, Salamero, O, Nagarajahastri, P, Sauer, T, Searle, E, Tovar, N, Vallet, N, Vaughan, L, Vega, G, Vyas, P, Platzbecker, U. Recommended Phase 2 Dose (RP2D) Determination of Bleximenib in Combination With Venetoclax plus Azacitidine (VEN plus AZA): Phase Ib Study in Newly Diagnosed (ND) and Relapsed/ Refractory (R/R) Acute Myeloid Leukemia (AML) With KMT2A or NPM1 Alterations. Clinical Lymphoma Myeloma & Leukemia. 2025; 25DOI:. PMID:. IF:2.700(Q2/4D).
01/09/2025
Characteristics of Long-Term Survivors in Multiple Myeloma: Exploring Factors for Cure After Extended Follow-Up
Fernandez, RA, Arroyo, A, Cedena, MT, Rosiñol, L, De la Rubia, J, Miqueleiz, S, González-Calle, V, de Arriba, F, Casado-Montero, F, Hernandez, MT, Mas, M, Fernandez-Abellan, P, Rodriguez-Otero, P, Calle, C, Abella, E, Ribas, P, Alegre, A, Bergua, JM, Ocio, E, De la Cruz, J, Mateos, MV, San-Miguel, J, Bladé, J, Lahuerta, JJ, Martinez-Lopez, J. Characteristics of Long-Term Survivors in Multiple Myeloma: Exploring Factors for Cure After Extended Follow-Up. Clinical Lymphoma Myeloma & Leukemia. 2025; 25DOI:. PMID:. IF:2.700(Q2/4D).
01/09/2025
Denervated human muscle fibers promote reinnervation via neurotrophic factor release in SMA and ALS
Gokul-Nath, R, Collins, C, Valverde, L, Lleixa, C, Verdu-Diaz, J, Di Lorenzo, A, Llarch, P, Querol, L, Marini-Bettolo, C, Rojas-Garcia, R, Diaz-Manera, J. Denervated human muscle fibers promote reinnervation via neurotrophic factor release in SMA and ALS. NEUROMUSCULAR DISORDERS. 2025; 53DOI:10.1016/j.nmd.2025.105462. PMID:. IF:2.800(Q2/5D).
01/09/2025
Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum
Franquesa-Mullerat, M, Morcillo-Nieto, AO, Arriola-Infante, JE, Zsadanyi, SE, Vaqué-Alcázar, L, Rozalem-Aranha, M, Arranz, J, Rodríguez-Baz, I, Maure-Blesa, L, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Giménez, S, Alcolea, D, Belbin, O, Lleó, A, Carmona-Iragui, M, Fortea, J, Bejanin, A. Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum. ALZHEIMERS & DEMENTIA. 2025; 21(9)DOI:10.1002/alz.70581. PMID:40968330. IF:11.100(Q1/1D).
01/09/2025
Gender and socioeconomic inequalities in adolescent mental well-being in Barcelona: a repeated cross-sectional study
Olivella-Cirici, M, Vilagut, G, Sánchez-Ledesma, E, Serral, G, Cortés-Albaladejo, M, Cejas, PM, Pasarín, M, Alonso, J, Pérez, G. Gender and socioeconomic inequalities in adolescent mental well-being in Barcelona: a repeated cross-sectional study. Journal Of Public Health-Heidelberg. 2025; DOI:10.1007/s10389-025-02573-3. PMID:. IF:(Q/D).
01/09/2025
Bimekizumab efficacy in patients with plaque psoriasis: A post hoc stratification by weight over 4 years in BE BRIGHT
Gkini, MA, López-Ferrer, A, Magnolo, N, Soung, J, Trafford, A, Pousa, ID, Kavanagh, S, Gooderham, M. Bimekizumab efficacy in patients with plaque psoriasis: A post hoc stratification by weight over 4 years in BE BRIGHT. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).